Blockchain Registration Transaction Record

Aclarion Wins Top AI Award for Chronic Back Pain Diagnostic Breakthrough

Aclarion wins Diamond Pinnacle Award for AI innovation in chronic low back pain diagnosis. Nociscan platform uses biomarkers & algorithms to identify painful discs with 97% surgical success rate when used with other tools.

This development matters because chronic low back pain represents one of the most significant healthcare burdens globally, affecting millions of people and costing healthcare systems billions annually in treatment expenses and lost productivity. Traditional diagnostic methods for discogenic pain often rely on subjective patient reports and imaging that may not accurately identify pain sources, leading to ineffective treatments, unnecessary procedures, and prolonged patient suffering. Aclarion's Nociscan technology addresses this critical gap by providing objective, biochemical data that helps physicians pinpoint the exact source of pain with greater accuracy. For patients, this means more targeted treatments, potentially higher success rates for interventions like surgery (97% success rate when Nociscan-positive discs are treated), and reduced trial-and-error approaches that delay relief. For healthcare systems, it offers the potential to reduce costs associated with ineffective treatments and repeated procedures while improving patient outcomes. The cloud-based nature of the platform also makes this advanced diagnostic capability accessible without major infrastructure investments, potentially democratizing access to precision spine care across different healthcare settings.